In vivo and in vitro antitumor activities of tuftsin.
D000818:Animals; D002460:Cell Line; D003602:Cytotoxicity, Immunologic; D005260:Female; D006098:Granulocytes / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology; D007942:Leukemia, Experimental / Q000188:drug therapy; D008264:Macrophages / Q000276:immunology; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D001357:Sarcoma, Avian / Q000188:drug therapy; D014405:Tuftsin / Q000494:pharmacology / Q000627:therapeutic use*
D014405:Tuftsin